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Introduction
disease of the central nervous system that often af-
fects young patients and leads to a progressive neu-
rological defect. Relatively recent studies have con-
in MS is not mostly related to demyelination, but 
to an axonal and neuronal loss (1–4). The necessity 
for the closer analysis of axonal tissue arises from the 
fact that there is a growing need to develop biomark-
ers for monitoring the disease progress and modeling 
the prognosis as well as the evaluation of treatment 
effectiveness (5). An acute episode of optic neuritis 
(ON) is observed in 30%–70% of MS patients dur-
ing the course of the disease (6, 7). The damage of 
vision pathways is an ideal model for neurodegenera-
tive processes in MS (8), which theoretically might 
coherence tomography (OCT) captures images from 
the retina (9), the only place in a human body where 
the investigation of the axonal tissue layer is possible 
in vivo regardless of the myelin sheath condition. It 
has repeatedly been shown that damage to the retinal 
can be detected even in patients without a history 
of an acute episode of ON, suggesting of subclini-
cal and progressive damage of the afferent visual sys-
tem (10–13). A neurophysiological method – visual 
evoked potentials (VEPs) – has already been used 
for the evaluation of axonal optic nerve damage for 
many years. This method was also mentioned in the 
McDonald’s criteria used for the diagnostics of MS 
in 2001 and 2005 (14, 15). The loss of axonal tissue 
is characterized by changes in the VEP amplitude, 
but the prolongation of latency refers to optic nerve 
demyelination (16). The aim of our study was to ana-
lyze the clinical utility of VEP and OCT in the diag-
nosis of optic nerve axonal damage and to determine 
the correlation between the RNFLT thickness, which 
is considered a structural parameter of the retina, and 
the VEP amplitude, a functional visual parameter, in 
MS patients with and without a history of acute ON.
Material and Methods
The cross-sectional study included 69 relapsing-
remitting MS patients with and without a history of 
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ON, recruited from the Multiple Sclerosis Center at 
Pauls Stradins Clinical University Hospital. A his-
tory of ON was documented based on symptoms 
and clinical signs (17). However, not all patients had 
a documented episode of ON. The study involved 
months before examinations. The mean time after 
an episode of ON was 19.2 months. Patients were 
not given corticosteroid therapy for at least 30 days 
before the study, while some patients continued 
immunomodulatory treatment. Patients suffering 
from neurological diseases other than MS and oph-
thalmological or systemic ones that could affect the 
afferent visual system were not included into the 
study. MS diagnosis was established by a neurologist 
according to the McDonald’s criteria. A neurologi-
cal examination with impairment assessed using the 
Kurtzke Expanded Disability Status Scale (EDSS) 
was performed. The EDSS is based on data from 
the neurological examination and patient’s ability to 
walk. Scores range from 0 (indicating no neurologic 
impairment) to 10 (death due to MS). An experi-
enced ophthalmologist performed a complete oph-
thalmologic examination: determination of visual 
acuity, measurement of ocular tension, biomicros-
All the patients underwent the pattern-rever-
sal VEP stimulation in a dark and quiet room for 
both eyes by using the RETI-port 21 (Roland Con-
sult, Germany). Subjects were seated at a distance 
the gaze at the red dot in the center of the screen. 
Full correction of refraction was performed if neces-
sary. Active and reference gold disc electrodes were 
placed at Oz and Fz, respectively, according to the 
international 10–20 system. The monocular stimula-
tion of vision with the black-white video monitor at 
a frequency of 1.6 Hz was performed, and stimulus 
patterns were presented on a video screen subtend-
ing 12×15 degrees of visual angle with a pattern 
and analyzed by means of repeated (100) stimula-
tions 2 times for each eye. N75/P100 amplitudes 
were measured. The VEP amplitude was evaluated 
based on the laboratory-designed reference value, to 
assume amplitude under 8.2 μV as an abnormal one. 
The RNFLT thickness in 6 standard sectors 
(temporal, temporal upper, temporal lower, nasal, 
nasal upper, and nasal lower) was measured for all 
subjects on OCT (Heidelberg Engineering SPEC-
TRALIS) using the TruTrackTM active eye-tracking 
system. All the scans were performed by the same 
experienced ophthalmologist. Poor-quality scans 
were excluded. The RNFLT thickness in the ref-
erence range was represented by the green back-
ground. The presence of the defect was determined 
based on the machine normative database; a red col-
The patients with MS were divided into 2 groups. 
history of unilateral ON. The second group com-
prised 44 patients without a history of ON. The con-
trol group consisted of 14 age-matched individuals.
Descriptive statistics were used for data presenta-
tion and analysis. The chi-square test or the Fisher 
exact test was used to evaluate qualitative variables. 
Quantitative variables for both the groups were ana-
lyzed using the Student t test. Correlation was as-
sessed by the Spearmen correlation. The receiver 
operating characteristic (ROC) curve and the area 
under the curve were analyzed. The MedCalc 12.0 
differences between the areas under ROC curves. 
P<0.05.
Results
The study included 25 eyes affected by ON, 25 
contralateral, unaffected eyes of the same group, 
and 88 eyes of MS patients without a history of ON. 
The age of the patients ranged from 17 to 65 years. 
-
ing the study groups (t=1.90, P=0.06). The mean 
EDSS score of MS patients was 1.94. The disease 
duration ranged from 0 to 400 months. The clini-
cal and demographic characteristics of the patients 
included in the study are summarized in Table 1.
Table 2 shows the comparison of the mean VEP 
amplitude between MS patients with and without a 




Age, mean (SD), years 39.54 (10.35) 38.32 (10.77)
Men/women, n 10/15 16/28
Disease duration, mean 
(range), months 57.61 (0–384) 52.12 (0–400)
Months from ON 
episode, mean (range) 19.2 (6–120) 0
EDSS, mode (range) 3.5 (0–6) 0 (0–6)
EDSS, Expanded Disability Status Scale; ON, optic neuritis.
Clinical and Demographic Characteristics 



















Values are mean (standard deviation). VEP, visual evoked poten-
ON, optic neuritis.
The Mean Visual Evoked Potential Amplitude and 
Retinal Nerve Fiber Layer Thickness for Eyes Affected and 
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was found between the RNFLT thickness and the 
mean VEP amplitude in the MS patients with a his-
tory of ON (rs=0.42, P=0.01) as well as in the MS 
patients without a history of ON (rs=0.44, P<0.001). 
The abovementioned relationships are depicted in 
-
served in the control group (P=0.47). 
A separate analysis of the MS patients’ popula-
tion with a history of ON revealed an abnormally 
reduced RNFLT thickness in 16 ON-affected eyes 
(64%), while a decrease in the mean VEP amplitude 
was observed in 18 cases (72%).
Similar results were obtained studying the other 
ON-unaffected eye of the same patients’ popula-
tion, to assess a subclinical optic nerve involvement. 
The reduced RNFLT thickness was found in 6 eyes 
(24%) and the decreased mean VEP amplitude in 
11 cases (44%).
By using the combination of both methods in 
the ON-affected eyes, abnormalities were detected 
in 13 cases (52%). However, regarding the ON-un-
affected eyes, optic nerve damage was documented 
in 4 eyes (16%).
While seeking for an answer to the question how 
high the possibility is to make mistakes by using 
only one method, it turned out that in the ON-
affected eyes with a normal mean VEP amplitude, 
(12%), while in case of the normal RNFLT thick-
ness, the average VEP amplitude was reduced in 5 
cases (20%). Similarly analyzing the other ON-un-
affected eyes, the average VEP amplitude was nor-
mal with an abnormal RNFLT thickness in 2 cases 
(8%), while 7 cases (28%) had a reduced average 
VEP amplitude with the normal RNFL thickness. 
It was observed that between ON history and 
presence of a reduced VEP amplitude there exists 
P=0.04), and 
such relevance was approved also between the his-
tory of ON and the presence of the decreased RN-
FLT thickness (P=0.03).
Referring to the ROC curve analysis and setting 
the clinical ON signs as the gold standard, the sen-
case were 64% and 90%, respectively, with the diag-
nostic accuracy being 74%. Similarly, measuring the 
RNFLT thickness and setting the ON clinical signs 















































Comparison of Diagnostic Accuracy
the temporal quadrant (RNFLT) thickness and average visual 
evoked potential (VEP) amplitude in ON diagnostics using 
ROC curves
as the gold standard, the corresponding values of 
OCT were 50%, 100%, and 73%, respectively. The 
positive predictive value of the RNFLT thickness 
measured by OCT was greater than that of the VEP 
amplitude (Table 3). 
difference (P=0.75) in the area under the ROC 
curve comparing the RNFLT thickness (AUC=0.82; 
95% CI, 0.70 to 0.93, P<0.001) and the mean VEP 
















amplitude (AUC=0.80; 95% CI, 0.68 to 0.92, 
P<0.001) in determining ON (Fig. 2). 
Discussion
Similar to previous studies (11–13, 18, 19), our 
damage in ON-unaffected eyes can be diagnosed by 
using the measurements of both the VEP amplitude 
and the RNFLT thickness. These results support the 
need to apply these tests to MS patients even with-
out a history of ON in order to get the picture of ax-
onal optic nerve lesions. In addition, both of these 
methods are useful in equivocal clinical situations, 
when the symptoms of ON are weakly expressed or 
the patient is not able to assess them adequately due 
to cognitive impairment.
Relying on the data obtained, our study showed 
an equally strong correlation between the mean 
VEP amplitude and the RNFLT thickness both in 
the eyes with or without a history of ON. In ad-
dition, our results indicated a correlation between 
the reduced VEP amplitude and decreased RNFLT 
thickness in the patients with a history of ON. This 
concurs with the data in literature and supports 
the use of these 2 methods to detect ON. Both the 
measurements of the RNFLT thickness by OCT and 
the VEP amplitude in the AUC analysis are equally 
qualitative parameters for the diagnostics of optic 
nerve damage due to ON. However, using the OCT 
method, optic nerve damage was diagnosed in fewer 
cases as compared with the VEP method both in the 
eyes affected and unaffected by ON.
sensitivity by 14% lower as compared with VEP, and 
it was lower than that reported in the literature (18). 
Nevertheless, OCT had a higher positive predic-
tive value, which can be explained by well-designed 
cutoff values in the device normative database. One 
of the explanations for the low sensitivity of OCT 
could be the fact that only the anterior visual path-
way can be assessed by this test, meanwhile the VEP 
can provide an insight into the integrity of both the 
anterior and posterior visual pathways. Moreover, it 
should be taken into account that after an ON epi-
sode, axonal damage could be secondary to demy-
elination, but the reduction in the RNFLT thick-
ness proceeds retrograde and is therefore not always 
complete. To improve the sensitivity of OCT, some 
authors (20–22) have recently offered the measure-
ments of the neuronal ganglion cell layer and the 
inner plexiform layer, which should indicate axonal 
damage more accurately than the measurements of 
the RNFLT, as these structures contain no addi-
tional glial tissues and blood vessels (23). Mistakenly 
thicker RNFLT could also be caused by possible glial 
tissue replacement for axonal tissue loss, which is 
included in the total RNFLT thickness. However, it 
should be noted that the measurements of the gan-
glion cell neuronal layer and the inner plexiform 
layer are possible only through manual segmenta-
tion, which is a relatively time-consuming process 
and therefore may be hardly ever applied in clinical 
practice.
Conclusions
The obtained results suggest that despite a sig-
and the VEP amplitude, the diagnosis of both clini-
cal and subclinical optic nerve damages is made 
more convincingly by using VEP. From this conclu-
sion it follows that if circumstances require using a 
single method for the approval of an ON history, 
VEP is more preferred. However, the combination 
of the VEP and OCT methods would facilitate the 
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